Nombre de documents


CV de Hubert Marotte

Article dans une revue4 documents

  • Jacques Gottenberg, Olivier Brocq, Aleth Perdriger, Slim Lassoued, Jean Berthelot, et al.. Non–TNF-Targeted Biologic vs a Second Anti-TNF Drug to Treat Rheumatoid Arthritis in Patients With Insufficient Response to a First Anti-TNF Drug. Journal of the American Medical Association, American Medical Association (AMA), 2016, 316 (11), <10.1001/jama.2016.13512>. <hal-01374313>
  • Hubert Marotte, Pei-Suen Tsou, Tatiana Fedorova, Adam Pinney, Benjamin Lewis, et al.. Blocking the janus-activated kinase pathway reduces tumor necrosis factor alpha-induced interleukin-18 bioactivity by caspase-1 inhibition.. Arthritis Research & Therapy, BioMed Central, 2014, 16 (2), pp.R102. <10.1186/ar4551>. <inserm-00997797>
  • Candice Trocmé, Hubert Marotte, Athan Baillet, Béatrice Pallot-Prades, Jérome Garin, et al.. Apolipoprotein A-I and platelet factor 4 are biomarkers for infliximab response in rheumatoid arthritis.. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2009, 68 (8), pp.1328-33. <10.1136/ard.2008.093153>. <inserm-00382264>
  • Hubert Marotte, Gilles Paintaud, Herve Watier, Pierre Miossec. Rituximab-related late-onset neutropenia in a patient with severe rheumatoid arthritis. Annals of the Rheumatic Diseases, BMJ Publishing Group, 2008, 67 (6), pp.893-894. <hal-00616939>